{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:41:46Z","timestamp":1793814106195,"version":"4.6.1"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Osteoporosis is a common complication of acute fracture, which can lead to fracture delayed union or other complications and resulting in poor fracture healing. Bisphosphate is a common anti-osteoporosis drug, but its application in fracture patients is still controversial because of its inhibitory effect on bone resorption.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Studies were acquired from literature databases in accordance with established inclusion criteria. Standard mean difference (SMD) and 95% confidence intervals (Cls) were calculated to evaluate the effectiveness of the bisphosphonates treatment in fracture patients. Data analysis was conducted with the Review Manager 5.4.1 software.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 16 studies involving 5022 patients obtained from selected databases were examined. As expected, bisphosphate had no significant effect on fracture healing time, but it could significantly increase BMD and prevent osteoporosis. Meanwhile, bisphosphate can inhibit both bone resorption and bone formation markers, resulting in low bone turnover state.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This meta-analysis showed that bisphosphonate have no significant effect on fracture healing time but they do increase the changes in BMD and reduce bone synthesis and resorption markers. Early application of bisphosphonates after injury in the appropriate patient population should be considered.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.688269","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T15:48:38Z","timestamp":1630684118000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":50,"title":["The Effect of Bisphosphonates on Fracture Healing Time and Changes in Bone Mass Density: A Meta-Analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Yongquan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deye","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muliang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lele","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangdong","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0172-4","article-title":"An Estimate of the Worldwide Prevalence and Disability Associated With Osteoporotic Fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporos Int"},{"key":"B2","doi-asserted-by":"publisher","first-page":"Itc17","DOI":"10.7326\/AITC201708010","article-title":"Osteoporosis","volume":"167","author":"Ensrud","year":"2017","journal-title":"Ann Intern Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7326\/M15-1361","article-title":"Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Intern Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-1383(16)47004-X","article-title":"Fracture Healing in Osteoporotic Bone","author":"Cheung","year":"2016","journal-title":"Injury"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2005.04.059","article-title":"Effects of Bisphosphonates on Proliferation and Osteoblast Differentiation of Human Bone Marrow Stromal Cells","volume":"26","author":"von Knoch","year":"2005","journal-title":"Biomaterials"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0952","article-title":"Severely Suppressed Bone Turnover: A Potential Complication of Alendronate Therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2002.17.12.2237","article-title":"Raloxifene, Estrogen, and Alendronate Affect the Processes of Fracture Repair Differently in Ovariectomized Rats","volume":"17","author":"Cao","year":"2002","journal-title":"J Bone Mineral Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.G.00864","article-title":"Low Incidence of Anti-Osteoporosis Treatment After Hip Fracture","volume":"90","author":"Rabenda","year":"2008","journal-title":"J Bone Joint Surg Am"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4416-x","article-title":"After the Fall: Improving Osteoporosis Treatment Following Hip Fracture","volume":"29","author":"Kuiper","year":"2018","journal-title":"Osteoporos Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1185\/030079904125003683","article-title":"The HORIZON Recurrent Fracture Trial: Design of a Clinical Trial in the Prevention of Subsequent Fractures After Low Trauma Hip Fracture Repair","volume":"20","author":"Colon-Emeric","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3109\/17453679808997793","article-title":"No Adverse Effects of Clodronate on Fracture Healing in Rats","volume":"69","author":"Madsen","year":"1998","journal-title":"Acta Orthop Scand"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.090209","article-title":"Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture","volume":"24","author":"Eriksen","year":"2009","journal-title":"J Bone Miner Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2014.05.034","article-title":"Zoledronic Acid Infusion for Lumbar Fusion in Osteoporosis Patients","volume":"192","author":"Tu","year":"2014","journal-title":"J Surg Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12891-016-1113-9","article-title":"Local Pamidronate Influences Fracture Healing in a Rodent Femur Fracture Model: An Experimental Study","volume":"17","author":"Menzdorf","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/jor.23316","article-title":"Earlier Effect of Alendronate in Mouse Metaphyseal Versus Diaphyseal Bone Healing","volume":"35","author":"Sandberg","year":"2017","journal-title":"J Orthop Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.14670\/HH-11-893","article-title":"Zoledronate Promotes Bone Formation by Blocking Osteocyte-Osteoblast Communication During Bone Defect Healing","volume":"33","author":"Cui","year":"2018","journal-title":"Histol Histopathol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/jbmr.3898","article-title":"Early Alendronate can be Safe During Fracture Healing","volume":"35","author":"Fung","year":"2020","journal-title":"J Bone Miner Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2018.04.017","article-title":"Healing of Fractures in Osteoporotic Bones in Mice Treated With Bisphosphonates - A Transcriptome Analysis","volume":"112","author":"Hauser","year":"2018","journal-title":"Bone"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/17453674.2016.1188258","article-title":"Zoledronic Acid In Vivo Increases In Vitro Proliferation of Rat Mesenchymal Stromal Cells","volume":"87","author":"Heino","year":"2016","journal-title":"Acta Orthop"},{"key":"B20","doi-asserted-by":"publisher","first-page":"36129","DOI":"10.1038\/srep36129","article-title":"Skeletal Site-Specific Effects of Zoledronate on In Vivo Bone Remodeling and In Vitro Bmscs Osteogenic Activity","volume":"7","author":"Gong","year":"2017","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015: Elaboration and Explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s Tool for Assessing Risk of Bias in Randomised Trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring Inconsistency in Meta-Analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12494","article-title":"The Effects of Clinical and Statistical Heterogeneity on the Predictive Values of Results From Meta-Analyses","volume":"20","author":"Melsen","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"B25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/000164700317413193","article-title":"Clodronate Increases Mineralization of Callus After Colles\u2019 Fracture: A Randomized, Double-Blind, Placebo-Controlled, Prospective Trial in 32 Patients","volume":"71","author":"Adolphson","year":"2000","journal-title":"Acta Orthop Scand"},{"key":"B26","article-title":"The Effect of Risedronate Treatment on Bone Turnover Markers in Patients With Hip Fracture","volume":"41","author":"Altinta\u015f","year":"2007","journal-title":"Acta Orthop Traumatol Turc"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-008-0767-z","article-title":"Effect of Alendronate in Elderly Patients After Low Trauma Hip Fracture Repair","volume":"20","author":"Cecilia","year":"2009","journal-title":"Osteoporos Int"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-011-9474-4","article-title":"Clinical Risk Factors for Recurrent Fracture After Hip Fracture: A Prospective Study","volume":"88","author":"Col\u00f3n-Emeric","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.K.01434","article-title":"Early Initiation of Bisphosphonate Does Not Affect Healing and Outcomes of Volar Plate Fixation of Osteoporotic Distal Radial Fractures","volume":"94","author":"Gong","year":"2012","journal-title":"J Bone Joint Surg Am"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3109\/17453674.2011.594231","article-title":"A Single Bisphosphonate Infusion Does Not Accelerate Fracture Healing in High Tibial Osteotomies","volume":"82","author":"Harding","year":"2011","journal-title":"Acta Orthop"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.94B7.29079","article-title":"Does Early Administration of Bisphosphonate Affect Fracture Healing in Patients With Intertrochanteric Fractures","volume":"94","author":"Kim","year":"2012","journal-title":"J Bone Joint Surg Br"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-012-1283-7","article-title":"The Relation Between Zoledronic Acid Infusion and Interbody Fusion in Patients Undergoing Transforaminal Lumbar Interbody Fusion Surgery","volume":"154","author":"Li","year":"2012","journal-title":"Acta Neurochir (Wien)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2868","article-title":"Reduction in the Risk of Clinical Fractures After a Single Dose of Zoledronic Acid 5 Milligrams","volume":"98","author":"Reid","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jhsa.2008.12.011","article-title":"Comparison of Radiographic Fracture Healing in the Distal Radius for Patients on and Off Bisphosphonate Therapy","volume":"34","author":"Rozental","year":"2009","journal-title":"J Handb Surg Am"},{"key":"B35","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/01.PHM.0000122877.28631.23","article-title":"Beneficial Effect of Etidronate Therapy in Immobilized Hip Fracture Patients","volume":"83","author":"Sato","year":"2004","journal-title":"Am J Phys Med Rehabil"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S146871","article-title":"Percutaneous Kyphoplasty Combined With Zoledronic Acid Infusion in the Treatment of Osteoporotic Thoracolumbar Fractures in the Elderly","volume":"13","author":"Shi","year":"2018","journal-title":"Clin Interv Aging"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.95B11.31652","article-title":"Effect of Early Administration of Alendronate After Surgery for Distal Radial Fragility Fracture on Radiological Fracture Healing Time","author":"Uchiyama","year":"2013","journal-title":"Bone Joint J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2002.17.12.2247","article-title":"Alendronate in the Prevention of Bone Loss After a Fracture of the Lower Leg","volume":"17","author":"van der Poest Clement","year":"2002","journal-title":"J Bone Miner Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-019-04896-w","article-title":"Zoledronic Acid Combined With Percutaneous Kyphoplasty in the Treatment of Osteoporotic Compression Fracture in a Single T12 or L1 Vertebral Body in Postmenopausal Women","volume":"30","author":"Zhang","year":"2019","journal-title":"Osteoporos Int"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3679","article-title":"Effect of Alendronic Acid on Fracture Healing: A Multicenter Randomized Placebo-Controlled Trial","volume":"34","author":"Duckworth","year":"2019","journal-title":"J Bone Mineral Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2020.06.004","article-title":"Osteoporosis in Older Adults","volume":"104","author":"Johnston","year":"2020","journal-title":"Med Clin North Am"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90350-X","article-title":"Four-Year Study of Intermittent Cyclic Etidronate Treatment of Postmenopausal Osteoporosis: Three Years of Blinded Therapy Followed by One Year of Open Therapy","volume":"95","author":"Harris","year":"1993","journal-title":"Am J Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199005033221803","article-title":"Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women With Postmenopausal Osteoporosis","volume":"322","author":"Storm","year":"1990","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20780","article-title":"A Systematic Review and Economic Evaluation of Bisphosphonates for the Prevention of Fragility Fractures","volume":"20","author":"Davis","year":"2016","journal-title":"Health Technol Assess"},{"key":"B45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijsu.2018.02.007","article-title":"Risedronate Reduces Postoperative Bone Resorption After Cementless Total Hip Arthroplasty: A Systematic Review and Meta-Analysis","volume":"52","author":"Wang","year":"2018","journal-title":"Int J Surg"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic Acid and Clinical Fractures and Mortality After Hip Fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N Engl J Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-016-3840-z","article-title":"Osteonecrosis of the Jaw (ONJ) and Atypical Femoral Fracture (AFF) in an Osteoporotic Patient Chronically Treated With Bisphosphonates","volume":"28","author":"S\u00e1nchez","year":"2017","journal-title":"Osteoporos Int"},{"key":"B48","doi-asserted-by":"publisher","first-page":"i3365","DOI":"10.1136\/bmj.i3365","article-title":"Risk of Hip, Subtrochanteric, and Femoral Shaft Fractures Among Mid and Long Term Users of Alendronate: Nationwide Cohort and Nested Case-Control Study","volume":"353","author":"Abrahamsen","year":"2016","journal-title":"BMJ"},{"key":"B49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7326\/M19-0533","article-title":"Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention: A Systematic Review","volume":"171","author":"Fink","year":"2019","journal-title":"Ann Intern Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00198-008-0759-z","article-title":"The Relation Between Bisphosphonate Use and Non-Union of Fractures of the Humerus in Older Adults","volume":"20","author":"Solomon","year":"2009","journal-title":"Osteoporos Int"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345598","article-title":"Effect of Inappropriate and Continuous Therapy With Alendronate for Ten Years on Skeletal Integrity - Observations in Two Elderly Patients","volume":"31","author":"Tucci","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1097\/00003086-200303000-00036","article-title":"Long-Term Administration of Clodronate Does Not Prevent Fracture Healing in Rats","author":"Koivukangas","year":"2003","journal-title":"Clin Orthop Relat Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/BF00451880","article-title":"Clodronate Increases the Calcium Content in Fracture Callus. An Experimental Study in Rats","volume":"112","author":"Nyman","year":"1993","journal-title":"Arch Orthop Trauma Surg"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.orthres.2005.03.004","article-title":"A Single Systemic Dose of Pamidronate Improves Bone Mineral Content and Accelerates Restoration of Strength in a Rat Model of Fracture Repair","volume":"23","author":"Amanat","year":"2005","journal-title":"J Orthop Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/08941939.2017.1339151","article-title":"Clinical Efficacy Analysis of Percutaneous Kyphoplasty Combined With Zoledronic Acid in the Treatment and Prevention of Osteoporotic Vertebral Compression Fractures","volume":"31","author":"Liu","year":"2018","journal-title":"J Invest Surg"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2903-2","article-title":"Timing of the Initiation of Bisphosphonates After Surgery for Fracture Healing: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"26","author":"Li","year":"2015","journal-title":"Osteoporos Int"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of Action of Bisphosphonates: Similarities and Differences and Their Potential Influence on Clinical Efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.200500059","article-title":"Structural Basis for the Exceptional In Vivo Efficacy of Bisphosphonate Drugs","volume":"1","author":"Rondeau","year":"2006","journal-title":"ChemMedChem"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-010-1514-9","article-title":"Zoledronic Acid Results in Better Health-Related Quality of Life Following Hip Fracture: The HORIZON-Recurrent Fracture Trial","volume":"22","author":"Adachi","year":"2011","journal-title":"Osteoporos Int"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-004-1790-8","article-title":"Pamidronate Treatment of Pediatric Fracture Patients on Chronic Steroid Therapy","volume":"20","author":"Acott","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-0159-0","article-title":"Comparison of the Analgesic Efficacy of Pamidronate and Synthetic Human Calcitonin in Osteoporotic Vertebral Fractures: A Double-Blind Controlled Study","volume":"25","author":"Laroche","year":"2006","journal-title":"Clin Rheumatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/os.12460","article-title":"Study on Zoledronic Acid Reducing Acute Bone Loss and Fracture Rates in Elderly Postoperative Patients With Intertrochanteric Fractures","volume":"11","author":"Liu","year":"2019","journal-title":"Orthop Surg"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/BF00316285","article-title":"Specificity of Urinary Excretion of Cross-Linked N-Telopeptides of Type I Collagen as a Marker of Bone Turnover","volume":"54","author":"Rosen","year":"1994","journal-title":"Calcif Tissue Int"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s002239900497","article-title":"Application of a New Serum Assay for Type I Collagen Cross-Linked N-Telopeptides: Assessment of Diurnal Changes in Bone Turnover With and Without Alendronate Treatment","volume":"63","author":"Gertz","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/PL00005830","article-title":"Serum CTX: A New Marker of Bone Resorption That Shows Treatment Effect More Often Than Other Markers Because of Low Coefficient of Variability and Large Changes With Bisphosphonate Therapy","volume":"66","author":"Rosen","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3398-1","article-title":"Effects of Zoledronic Acid on Bone Fusion in Osteoporotic Patients After Lumbar Fusion","volume":"27","author":"Chen","year":"2016","journal-title":"Osteoporos Int"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1027","article-title":"Benefits and Risks of Bisphosphonate Therapy for Osteoporosis","volume":"97","author":"Khosla","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.688269\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T15:48:42Z","timestamp":1630684122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.688269\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":67,"alternative-id":["10.3389\/fendo.2021.688269"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.688269","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,30]]},"article-number":"688269"}}